Form 8-K Design Therapeutics, For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Wall St set for higher open after Micron revives AI optimism, upbeat economic data
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
Design Therapeutics appoints David Shapiro to board of directors
April 1, 2026 4:06 PM EDTDesign Therapeutics Inc. (NASDAQ: DSGN) appointed David Shapiro, M.D., to its board of directors as a Class III director, effective March 31, 2026. His term will end at the company's 2027 annual meeting of stockholders.
Shapiro was also appointed to serve on the company's Nominating and... More
